Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis

News   Feb 22, 2013

 
Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis
 
 
 

RELATED ARTICLES

Researchers Discover Key Link Between Mitochondria and Cocaine Addiction

News

Researchers were able to block response in mitochondria to cocaine.

READ MORE

Tuberculosis Vaccine Trial Results Offer Potential for BCG Revaccination

News

The study is the first 'prevention of infection' trial conducted for tuberculosis, the world's leading infectious disease killer.

READ MORE

Psoriasis Drug Also Reduces Aortic Inflammation

News

An antibody used to treat the autoimmune skin disease psoriasis is also effective at reducing aortic inflammation, a key marker of future risk of major cardiovascular events.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE